HFpEF and Atrial Fibrillation: The Enigmatic Interplay of Dysmetabolism, Biomarkers, and Vascular Endothelial Dysfunction.
Jure BosanacLara StrausMarko NovakovićDaniel KošutaMojca Božič-MijovskiJerneja TasičBorut JugPublished in: Disease markers (2022)
Our results have demonstrated that patients with HFpEF and AF have significantly lower leptin, irisin, and MDA levels compared to patients with HFpEF but without AF. These results offer new insights into the complexity of vascular function and cardiometabolic and oxidative stress biomarkers in the context of HFpEF, AF, and aging.
Keyphrases
- atrial fibrillation
- oxidative stress
- catheter ablation
- oral anticoagulants
- left atrial
- left atrial appendage
- direct oral anticoagulants
- heart failure
- percutaneous coronary intervention
- breast cancer cells
- ischemia reperfusion injury
- coronary artery disease
- venous thromboembolism
- diabetic rats
- cell death
- signaling pathway
- mitral valve
- heat shock protein